[1]
P. Terrier, H. Mouriesse, B. Loridon, M. Gotteland, F. May-Levin, and J.-C. Delarue, “Use of a Polyclonal Antibody for the Determination of the Prognostic Value of c-erbB-2 Protein Over-Expression in Human Breast Cancer”, AO, vol. 35, no. 1, pp. 23–30, Jan. 1996.